Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
NCT Number: NCT00609297
RATIONALE: Gathering information over time about cancer-related pain from patients in a hospice and their caregivers may help doctors learn more about pain control.
PURPOSE: This clinical trial is studying how well standard pain control works in hospice patients with cancer-related pain.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Nashville, Tennessee, 37232, United States
OBJECTIVES:
OUTLINE: Data regarding pain and pain management is obtained from three sources: the patient, the caregiver(s), and the medical records.
NOTE: *If a patient is not available for the scheduled home visit, the interview will take place over the phone; if a patient is hospitalized or transferred to the inpatient hospice facility, the patient interview will take place there.
NOTE: **Patients and primary caregivers are interviewed independently.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patient eligibility includes:
Caregiver eligibility will include:
Exclusion criteria
PRIOR CONCURRENT THERAPY:
The Research Nurse will conduct a chart review after the patient's death.
Other names: None specified
The questionnaires will be completed at the end of week 1, week 2 and week 4.
Other names: None Specified
Given to patient and caregivers throughout the study
Other names: none specified
Time frame: date on study to death
Vanderbilt-Ingram Cancer Center
Other
Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part A
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04970121
Chemotherapy-induced Peripheral Neuropathy, Neurologic Manifestations
Bengbu, Anhui, China
View Trial DetailsNCT07025161
Neurologic Manifestations, Pain
Orlando, Florida, United States
View Trial DetailsNCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT06869369
Behavior, Motor Activity
Kütahya, Turkey (Türkiye)
View Trial Details